전일 마감가:
$1,055.67
열려 있는:
$1067.38
하루 거래량:
698.13K
Relative Volume:
0.97
시가총액:
$164.63B
수익:
$27.61B
순이익/손실:
$7.13B
주가수익비율:
26.06
EPS:
40.764
순현금흐름:
$3.76B
1주 성능:
+0.76%
1개월 성능:
+10.10%
6개월 성능:
-4.03%
1년 성능:
-5.44%
블랙록 Stock (BLK) Company Profile
명칭
Blackrock Inc
전화
(212) 810-5800
주소
50 HUDSON YARDS, NEW YORK
Compare BLK vs BX, BN, BAM, APO
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BLK
Blackrock Inc
|
1,062.14 | 163.62B | 27.61B | 7.13B | 3.76B | 40.76 |
|
BX
Blackstone Inc
|
132.60 | 103.99B | 16.59B | 6.83B | 869.79M | 4.4576 |
|
BN
Brookfield Corp
|
42.08 | 102.14B | 77.61B | 4.06B | -8.36B | 0.497 |
|
BAM
Brookfield Asset Management Ltd
|
47.56 | 74.01B | 5.07B | 2.48B | 2.37B | 1.5532 |
|
APO
Apollo Global Management Inc
|
124.24 | 70.69B | 31.69B | 2.94B | 8.43B | 1.5206 |
블랙록 Stock (BLK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-23 | 업그레이드 | UBS | Neutral → Buy |
| 2026-01-14 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-12-11 | 재개 | UBS | Neutral |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2024-09-12 | 개시 | Wells Fargo | Overweight |
| 2024-08-27 | 개시 | Barclays | Overweight |
| 2024-01-16 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-12-15 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-12-12 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2023-07-10 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2023-07-03 | 재확인 | JP Morgan | Overweight |
| 2023-05-19 | 개시 | Citigroup | Buy |
| 2022-12-15 | 개시 | Wells Fargo | Overweight |
| 2022-10-19 | 개시 | Credit Suisse | Neutral |
| 2022-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-03-08 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2021-11-03 | 재개 | BofA Securities | Buy |
| 2020-10-01 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-02-14 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2020-01-02 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2019-11-06 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
| 2019-03-08 | 재확인 | BofA/Merrill | Buy |
| 2019-01-29 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-01-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2018-12-06 | 재확인 | BofA/Merrill | Buy |
| 2018-07-13 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2018-06-18 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-25 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2017-09-08 | 개시 | Barclays | Overweight |
| 2017-01-04 | 다운그레이드 | Goldman | Buy → Neutral |
| 2016-10-19 | 재확인 | UBS | Buy |
| 2016-09-09 | 재확인 | Deutsche Bank | Buy |
| 2016-07-15 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2016-06-16 | 재확인 | Deutsche Bank | Buy |
| 2016-04-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-04-15 | 재확인 | UBS | Buy |
모두보기
블랙록 주식(BLK)의 최신 뉴스
BlackRock® Canada Announces Final July Cash Distributions for the iShares® Premium Money Market ETF - GlobeNewswire
BlackRock Raises $12.5 Billion of Debt for Meta Data Center - Bloomberg.com
BlackRock Dodges AI Bond Flop as $12.3 Billion Debt Deal Rallies - Yahoo Finance
BlackRock (NYSE: AMC-related) discloses 5.5% beneficial ownership in AMC - Stock Titan
BlackRock (COGT holder) discloses 8.0% ownership in Cogent Biosciences common stock - Stock Titan
BlackRock, Inc. (CRBP) discloses 5.9% beneficial ownership in Corbus Pharmaceuticals - Stock Titan
BlackRock (ALAB holder) discloses 7.4% beneficial stake in Astera Labs - Stock Titan
BlackRock (BETR holder) discloses 5.2% Better Home & Finance Class A ownership - Stock Titan
BlackRock (NYSE: BLK) reports 7.2% beneficial stake in Caribou Biosciences (CRBU) - Stock Titan
BlackRock (CODI holder) discloses 3.98M-share, 5.3% stake in Compass Diversified - Stock Titan
BlackRock (NYSE: LODE custodian) discloses 5.6% beneficial stake in Comstock - Stock Titan
BlackRock (CEVA: CEVA) discloses 8.4% beneficial stake in CEVA Inc - Stock Titan
BlackRock (CDZI holder) discloses 6.0% beneficial stake in Cadiz Inc - Stock Titan
BlackRock (BNAI) discloses 5.1% beneficial ownership in Brand Engagement Network - Stock Titan
BlackRock (CIA) discloses 3.58M-share beneficial stake in Citizens, Inc. - Stock Titan
BlackRock discloses 6.2% Commercial Vehicle Group (CVGI) stake in 13G - Stock Titan
BlackRock, Inc. (BHB) discloses 8.0% ownership of Bar Harbor Bankshares common stock - Stock Titan
BlackRock (NYSE: BZAI filer) discloses 5.1% Blaize Holdings ownership on Schedule 13G - Stock Titan
BlackRock (APLD) holds 12.2M Applied Digital shares with 4.3% beneficial stake - Stock Titan
BlackRock (CHMG) discloses 5.3% Chemung Financial ownership in Schedule 13G - Stock Titan
BlackRock (ARAY holder) discloses 2.08M Accuray Inc shares under 5% threshold - Stock Titan
BlackRock (ATYR holder) reports 1.8% beneficial stake in aTYR PHARMA INC - Stock Titan
BlackRock (CLPT holder) discloses 7.1% beneficial stake in ClearPoint Neuro - Stock Titan
California BanCorp (BCAL) gains BlackRock as 5.6% beneficial owner - Stock Titan
BlackRock discloses 52.5M Compass Inc (COMP) shares in 7% ownership filing - Stock Titan
BlackRock (CHPT holder) discloses 6.6% beneficial ownership in ChargePoint - Stock Titan
BlackRock (BYRN) discloses 383,826 Byrna Technologies shares in Schedule 13G/A - Stock Titan
BlackRock (BTSG holder) discloses 12% BrightSpring Health Services ownership in 13G/A - Stock Titan
BlackRock (BMBL holder) discloses 8.0M-share, 6.2% Bumble Inc. position - Stock Titan
BlackRock (CCCC) discloses 7.68M-share, 6.9% position in C4 Therapeutics - Stock Titan
BlackRock (NYSE: BLK) discloses 1.0% beneficial ownership in Skinhealth Systems (SKIN) - Stock Titan
BlackRock (CDNA) discloses 4.66M CareDx shares, a 9% beneficial stake - Stock Titan
BlackRock (ALIT holder) discloses 14.7M Alight Inc. Class A shares on 13G/A - Stock Titan
BlackRock (CRCT stakeholder) discloses 7.7% beneficial ownership in Cricut Class A - Stock Titan
BlackRock (CRDF holder) discloses 863,259 Cardiff Oncology shares in 13G/A - Stock Titan
BlackRock discloses 5.3% ownership of ARS Pharmaceuticals (SPRY) common stock - Stock Titan
BlackRock (CTRN holder) reports 5.6% beneficial stake in Citi Trends common stock - Stock Titan
BlackRock (CFBK holder) discloses 5.1% CF Bankshares stake in Schedule 13G - Stock Titan
BlackRock (BRZE holder) discloses 7.1% passive stake in Braze Class A - Stock Titan
BlackRock (CHRS holder) discloses 8.93M Coherus Oncology shares under sole control - Stock Titan
BlackRock (AVD holder) discloses 896,552 American Vanguard shares in ownership filing - Stock Titan
BlackRock Inc (AGYS) discloses 4.0M-share, 14.3% ownership in Agilysys - Stock Titan
BlackRock (BBIO holder) discloses 4.96% BridgeBio Pharma stake in amended 13G - Stock Titan
BlackRock, Inc. (AVBH) reports 5.4% beneficial stake in Avidbank Holdings - Stock Titan
BlackRock (ASAN) discloses 5.3% beneficial ownership stake in Asana Class A stock - Stock Titan
BlackRock (CNQ holder) discloses 117.9M-share, 5.7% stake in Canadian Natural Resources - Stock Titan
BlackRock (AGEN) discloses 2.51M-share, 6% stake in Agenus common stock - Stock Titan
BlackRock (CTNM stakeholder) reports 2.0M-share beneficial position in Therapeutics Inc - Stock Titan
BlackRock, Inc. (ACR) discloses 5.2% beneficial stake in ACRES Commercial Realty - Stock Titan
Americas CarMart (CRMT) sees BlackRock report 178,551-share, 2.2% ownership in 13G/A - Stock Titan
BlackRock (ALDX holder) discloses 1.7% Aldeyra Therapeutics stake in amended 13G - Stock Titan
블랙록 (BLK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):